Pharmaceuticals, Biotechnology and Life Sciences
With a website unveiled at the Innovation Expo and a presentation by its Regulatory Affairs Director, new DKT International program…
New molecular platform to access intracellular targets across a broad range of tumor cell types Opens up new range of…
Destiny Pharma has picked MedPharm to develop new topical formulations of its novel XF-platform compounds, new treatments for dermal and ocular infections which are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR).
The CHMP adopted two positive opinions recommending European Commission approval of: REVLIMID in combination with bortezomib and dexamethasone (RVd) in…
DUBLIN–(BUSINESS WIRE)–The “Metagenomics Market to 2027 – Global Analysis and Forecasts by Product, Application and Geography” report has been added…
VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM) announced today that the Independent Data Monitoring Committee (IDMC) for the Company’s pivotal…
–Initiated ZEPHYR, a pivotal Phase 2b/3 clinical study of livoletide for patients with Prader-Willi syndrome (PWS), in 1Q19– –Topline data…
DUBLIN–(BUSINESS WIRE)–The “Rheumatoid Arthritis Drugs Market- Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s offering.…
DUBLIN–(BUSINESS WIRE)–The “Global Preventive Vaccines Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s…
CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic…